ORENCIA® (Non-English)

Description

ORENCIA® is indicated for:

• Moderate to severe rheumatoid arthritis (RA)
• Psoriatic arthritis (PsA)
• Polyarticular juvenile idiopathic arthritis (pJIA)

It is often used when patients have had an inadequate response to conventional DMARDs such as methotrexate.

Key Product Insights (for SEO/content)

• Abatacept selective T-cell modulator
• Biologic DMARD for autoimmune diseases
• Inhibits T-cell activation pathways
• Treats RA, PsA, and juvenile arthritis
• Reduces inflammation and joint damage
• Available IV infusion or SC injection
• Proven long-term disease control